首页> 外国专利> New crystal form of sodium n - 4 - 2 - 2-amine-4, 7-dihydro-4-oxo-3h-pirrolo 2, 3-d - pirimidin-5-il ethyl benzoate - L-glutamic and its processing program

New crystal form of sodium n - 4 - 2 - 2-amine-4, 7-dihydro-4-oxo-3h-pirrolo 2, 3-d - pirimidin-5-il ethyl benzoate - L-glutamic and its processing program

机译:钠的新晶体形式-[4- [2- [2-胺-4,7-二氢-4-氧代-3h-吡咯] [2,3-d]-嘧啶-5-基]苯甲酸乙酯]- L-谷氨酸及其加工程序

摘要

It refers to a procedure for preparing a formula compound, which includes making pyrethrin [2,3-d] react at the position of formula 5 containing sodium hydroxide; R is a protective group of carboxi, such as methyl or ethyl ether. It also refers to N - [4 - [2 - (2-amino-4, 7-dihydro-4-oxo-3h-pirrolo [2, 3-d] pirimidin-5-i l] ethi] benzoil] - L-glutamic, which is characterized by X-ray derivative diagram. It also refers to a preparation procedure, including crystallization of discrete salts of a compound into an appropriate solvent,Adjust the pH value of the aqueous solution from 7.5 to 8.0. Glassy compounds are inhibitors of different enzymes that need to be used to treat Mesothelioma Cancer.
机译:它是指制备式化合物的方法,该方法包括使除虫菊酯[2,3-d]在含氢氧化钠的式5位反应。 R是羧基的保护基,例如甲基或乙醚。它还指N-[4- [2-(2-氨基-4,7-二氢-4-氧代-3h-吡咯[2,3-d]嘧啶-5-il]乙]苯甲]]-L-谷氨酸,由X射线衍生图表征,也指制备步骤,包括将化合物的离散盐结晶至合适的溶剂中,将水溶液的pH值从7.5调节至8.0,玻璃状化合物是抑制剂需要用于治疗间皮瘤癌症的各种酶。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号